Abstract

BackgroundQuantification of T-cell receptor (TCR) chain families can be utilized for detection of clonal T-cell populations. Besides southern blotting and antibody-based approaches, quantitative real time PCR (qRT PCR) has been more widely applied in this context during the last years. Here, the heterogeneity of sequences within single families is the most challenging problem for exact quantification.MethodVβ-families were quantified using a universal reverse primer and family-specific forward primers with TaqMan technology on a light cycler instrument. Relative concentrations were calculated considering slopes and crossing points of each PCR reaction. Total expression of α/β TCR was assessed by quantification of the constant α-chain as a further control.ResultsThe method was tested by serial dilutions of clonal T-cells in mononuclear cells from healthy volunteers. Calculated percentages were in good correspondence with qRT PCR results demonstrating high reliability. Duplicates showed excellent technical reproducibility. We analyzed blood samples of 20 healthy volunteers for determination of mean and standard deviation for each family. The method was applied both to tissue and blood samples from patients with carcinomas and hematological disorders.ConclusionWe introduce a versatile method for the relative quantification of Vβ-families by real time PCR. The experimental strategy described allows the identification of alterations in the Vβ-family repertoire.

Highlights

  • Quantification of T-cell receptor (TCR) chain families can be utilized for detection of clonal T-cell populations

  • We introduce a versatile method for the relative quantification of Vβ-families by real time PCR

  • The experimental strategy described allows the identification of alterations in the Vβfamily repertoire

Read more

Summary

Methodology

Sebastian Ochsenreither*1, Alberto Fusi, Antonia Busse, Dirk Nagorsen, David Schrama, Jürgen Becker, Eckhard Thiel and Ulrich Keilholz. Address: 1University Hospital Benjamin Franklin, Medizinische Klinik III, Hematology, Oncology, and Transfusion Medicine, Charité Universitätsmedizin Berlin, 12200, Berlin, Germany and 2University of Würzburg, Clinic for Dermatology, Allergology, and Venerology, 97080, Würzburg, Germany. Published: 1 July 2008 Journal of Translational Medicine 2008, 6:34 doi:10.1186/1479-5876-6-34.

Results
Background
Methods
Results and Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.